Anixa Biosciences Inc - Common Stock (ANIX)

CUSIP: 03528H109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
35,258,614
Total 13F shares
1,596,826
Share change
+214,392
Total reported value
$4,888,000
Price per share
$3.06
Number of holders
18
Value change
+$720,757
Number of buys
12
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 03528H109?
CUSIP 03528H109 identifies ANIX - Anixa Biosciences Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q2 2020

As of 30 Jun 2020, Anixa Biosciences Inc - Common Stock (ANIX) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,596,826 shares. The largest 10 holders included VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, Bank of New York Mellon Corp, MILLENNIUM MANAGEMENT LLC, Qube Research & Technologies Ltd, MORGAN STANLEY, and SEGALL BRYANT & HAMILL, LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.